| Natalie Laura Albala, MD | |
|
1080 First Colonial Rd Ste 200, Virginia Beach, VA 23454-2406 | |
| (757) 395-6630 | |
| Not Available |
| Full Name | Natalie Laura Albala |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 1080 First Colonial Rd Ste 200, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629179650 | NPI | - | NPPES |
| 891373M | Medicaid | NC | |
| 1373M | Other | NC | BC/BS OF NC |
| 379842 | Medicaid | SC | |
| P00165862 | Other | NC | MEDICARE RAILROAD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Home Care Services-virginia Beach | Chesapeake, VA | Home health agency |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Clinicians recently used 3D printing to help treat a woman with a degenerative condition of the spinal column.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
Researchers at Duke University in Durham, USA, have made an important discovery about the spike protein on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have a broad impact on vaccine studies.
› Verified 1 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Clinicians recently used 3D printing to help treat a woman with a degenerative condition of the spinal column.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
Researchers at Duke University in Durham, USA, have made an important discovery about the spike protein on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have a broad impact on vaccine studies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Laura Albala, MD 1080 First Colonial Rd Ste 200, Virginia Beach, VA 23454-2406 Ph: (757) 395-6630 | Natalie Laura Albala, MD 1080 First Colonial Rd Ste 200, Virginia Beach, VA 23454-2406 Ph: (757) 395-6630 |
News Archive
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Clinicians recently used 3D printing to help treat a woman with a degenerative condition of the spinal column.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
Researchers at Duke University in Durham, USA, have made an important discovery about the spike protein on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have a broad impact on vaccine studies.
› Verified 1 days ago
Haidr Agha, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 First Colonial Rd, Ste 200, Virginia Beach, VA 23454 Phone: 757-623-0005 Fax: 757-389-5383 | |
Howard Courtenay Harrison Sr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 First Colonial Rd, Suite 101, Virginia Beach, VA 23454 Phone: 757-496-9020 Fax: 757-481-0638 | |
Vincent Lee, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5516 Virginia Beach Blvd, Virginia Beach, VA 23462 Phone: 757-473-3969 | |
Dr. Sue Beth Hudson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 Newtown Rd, Virginia Beach, VA 23462 Phone: 757-497-0606 Fax: 757-497-0411 | |
Dr. Rosario Devera Hipol, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Independence Cir Ste 102, Virginia Beach, VA 23455 Phone: 757-499-6395 Fax: 757-499-8026 | |
Dr. Jonah Anyaogu Ulu Ezieme, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-2323 Fax: 757-827-2255 | |
Dr. James Richard Miller, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 First Colonial Rd Ste 300, Virginia Beach, VA 23454 Phone: 757-395-1760 Fax: 757-756-5148 |